Member Info for marik

StarBright, thanks for the concerns, I'm very familiar with the processes involved having associates who are fund managers. A squeeze at this level is based on ratios as per normal. The daily volumes are high and like any other squeeze it will impact the share price. The support levels at this point in time mean any declared shorts or at an individual level will hit panic mode.

That's been a fantastic seminar, much better than I expected. 2-3M lfts per month in the UK with european and asian capacity on standby. Medusa 19 on the ready and ava6000 going positive (pk will be positive later this year), huge huge news!

Conifer at 2.99% and remain a supportive SH.

That's been a very good seminar.

Excellent webinar so far

What really made me sit up was that Avacta are aimimg for 3-5 million tests per month. With more to come from Europe and RoW.

Likely to close.

Jupiter are not working on news, they work on basic ratios based on buy sell volume and estimated short percentages. Right now, it is not in their favour and they are likely to sell.

I agree, it's like they don't want anyone to know how good the test is. It's pushed the data up to 99.6%.

The accuracy puts affimers on a class of their own.

Special brew indeed.

Great find CO, I missed that altogether. That's exceptionally good news.

"Would be surprised if Jupiter don’t cash out within the next few weeks"

Oxygen, the high volume and strong buying pressure puts the short ratio at risk. Jupiter will use this data as a factor for cashing out.

3-5 million per month! Great news!

Yes gje I have to agree. Have you noticed that AffiDX® SARS-CoV-2 antigen lateral flow test is reaching for 3-5 million tests per month. Further capacity, if required, is being put in place in Europe and potentially in Asia.

Myles is a shorters nightmare.

https://mobile.twitter.com/MylesMcNulty/status/1443470416014610433

"The fact that the first patient at Royal Marsden has received their third cycle of AVA6000 is very telling"

It's more than telling, the accumulative dosage is above what is currently medicated for dox (chemo). This means that pk data will be positive - will done to Avacta!

You've missed the opportunity gje.

Spot on PAH, it's back to opening already which implies that there is strong buying pressure.

Yes, wyn welcome to the light side.